Jeffrey Stark, MD

Jeff Stark, MD, is vice president and head of medical immunology, UCB. He is also a rheumatologist by training and leads UCB’s medical affairs team across the key focus areas of dermatology and rheumatology.

Articles by Jeffrey Stark, MD

Jeffrey Stark, MD, vice president, head of medical immunology, UCB.

Real-World Data and Ongoing Research Into Bimekizumab-bkzx

ByCameron Santoro,Maggie L. Shaw,Jeffrey Stark, MD

February 26th 2025

Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of real-world data to understand the effectiveness of bimekizumab-bkzx in a broader context.

Jeffrey Stark, MD, vice president and head of medical immunology at UCB.

Enhancing Patient Access Through Navigation Assistance

ByCameron Santoro,Maggie L. Shaw,Jeffrey Stark, MD

February 24th 2025

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, analyzes the Bimzelx Navigate program, a comprehensive support system developed to empower patients prescribed bimekizumab-bkzx (Bimzelx; UCB).

Jeff Stark, MD, vice president, head of medical immunology, UCB.

Bimekizumab-bkzx Expands Treatment Options for Inflammatory Conditions

ByCameron Santoro,Maggie L. Shaw,Jeffrey Stark, MD

February 10th 2025

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals and the remaining challenges.